May 9, 2012
Presentation at Phacilitate's Immunotherapy Leaders' Forum
9-11 May, 2012, Barcelona, Spain
Apr 30, 2012
Presentation at the 8th annual protein engineering summit
30th April - 4th May 2012 | Park Plaza Hotel, Boston, MAÂ
Apr 24, 2012
Presentation at 2nd World Bispecific Antibody Summit
Harnessing the potential of Bispecific Antibodies
24 - 26 APRIL 2012, BERLIN
Feb 28, 2012
Presentation at Combination Approaches for Cancer Therapy
February 28th-29th 2012, Boston MA
Jan 30, 2012
Presentation at Phacilitate's Protein Therapeutics Forum
30th of January 2011 at the Washington Grand Hyatt, Washington DC
Nov 29, 2011
Presentation at European Antibody Congress 2011
29th Nov 2011 Starling Geneva Hotel & Conference Center Geneva
Oct 31, 2011
Presentation at BIO Europe 2011
31st of October - 2nd of November, CCD conference center, Dusseldorf, Germany
Oct 20, 2011
Presentation at BioProduction 2011
20 October 2011, Maritim proArte Hotel, Berlin, Germany
Sep 26, 2011
Presentation at World Bispecific Antibody Summit 2011
26 September 2011 | John B Hynes Veterans Convention Center, Boston, MA
Sep 19, 2011
Presentation at 4th Annual Antibody Discovery & Development Forum
19th of September, Bilderberg Garden Hotel, Amsterdam, The Netherlands
May 18, 2011
Presentation at Bio€quity Europe 2011
May 24 2011, Paris Marriott Rive Gauche, Paris, France
May 18, 2011
Presentation at B Cells and Protection: Back to Basics
16 June 2011 Hotel Eden Roc, Sant Feliu de Guixols, Spain
May 18, 2011
Presentation at BioProcessing, Biologics & Biotherapeutics Congress
21 July 2011Â Edinburgh Conference Centre, Edinburgh, Scotland
Nov 19, 2010
Presentation at Cell Line Development and Engineering 2011
16 February 2011 | Holiday Inn Munich City Centre, Munich, Germany
Oct 4, 2010
Presentation at 3rd Annual Antibody Engineering & Therapeutics Asia
10-12 November 2010 | Renaissance Shanghai Pudong Hotel, China
Oct 4, 2010
Presentation at 3rd Annual Protein Congress
27-28 October 2010, Kempinski Hotel Bristol Berlin, Germany
Dec 5, 2011
5th of December, Barcelona, Spain
Dr. Mark Throsby COO of Merus will give a presentation entitled: "The MeMo mouse: A discovery platform for therapeutic human antibodies with low immunogenicity" at the 4th Annual Immunogenicity Forum. The presentation will highlight Merus transgenic mouse platform MeMo™ and will take place on the 5th of December 2011 Barcalona, Spain.